You just read:

Regeneron Announces ANGPTL3/Evinacumab Publication in New England Journal of Medicine and Positive Phase 2 Data in People with HoFH

News provided by

Regeneron Pharmaceuticals, Inc.

May 24, 2017, 17:00 ET